Scarica l'app Stockscreener
0.6321
8.97%
-0.0622
Jasper Therapeutics Inc Azioni (JSPR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
| Cost Of Revenue |
9.345
|
- | - | - | - |
Operating Expenses
|
12.09%
19.17
|
21.80 | 25.29 | 19.89 | 15.99 |
| Operating Income/Loss |
12.09%
-19.17
|
-21.80 | -25.29 | -19.89 | -15.99 |
| Nonoperating Income/Loss |
23.35%
0.43
|
0.561 | 0.964 | 1.252 | 1.41 |
| Income/Loss From Continuing Operations Before Tax |
11.79%
-18.74
|
-21.24 | -24.32 | -18.64 | -14.58 |
| Income/Loss From Continuing Operations After Tax |
11.79%
-18.74
|
-21.24 | -24.32 | -18.64 | -14.58 |
|
Net Income/Loss
|
11.79%
-18.74
|
-21.24 | -24.32 | -18.64 | -14.58 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.74%
16.64
|
15.02 | 0.1422 | 15.00 | 14.99 |
| Diluted Average Shares |
10.74%
16.64
|
15.02 | 0.1422 | 15.00 | 14.99 |
| Basic Earnings Per Share |
19.86%
-1.13
|
-1.41 | -1.64 | -1.24 | -0.97 |
| Diluted Earnings Per Share |
19.86%
-1.13
|
-1.41 | -1.64 | -1.24 | -0.97 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.96%
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):